A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis

Bibliographic Details
Main Authors:	M Stevenson, M Lloyd Jones, E De Nigris, N Brewer, S Davis, J Oakley
Format:	Article
Language:	English
Published:	NIHR Journals Library 2005-06-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta9220

Similar Items

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01)

Once-monthly risedronate for postmenopausal osteoporosis
by: Kristina Casadei, et al.
Published: (2009-02-01)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
by: Yeesuk Kim, et al.
Published: (2020-07-01)

Profile of teriparatide in the management of postmenopausal osteoporosis
by: Andrea Sikon, et al.
Published: (2010-03-01)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
by: Hsing-Fang Lu, et al.
Published: (2020-01-01)

Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
by: Abdurrahman Yeter, et al.
Published: (2014-12-01)

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01)

Association between alendronate v.s raloxifene and esophageal diseases among patients with osteoporosis
by: Szu-Chia Tu, et al.
Published: (2012)

The Association between Cardiovascular Events and the Use of Osteoporosis Medications- Alendronate vs. Raloxifene
by: Pei-Yu Lu, et al.

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
by: Enrico M Messalli, et al.
Published: (2009-04-01)

Efficacy of alendronate and risedronate on bone mineral density in men with osteoporosis or osteopenia: a meta-analysis
by: Jehle, Karen, et al.
Published: (2013)

The effect of smoking on the response to raloxifene treatment in postmenopausal osteoporosis
by: Savaş Erdem, et al.
Published: (2012-12-01)

Alendronate improves QOL of postmenopausal women with osteoporosis
by: Hisaya Kawate, et al.
Published: (2010-04-01)

Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
by: Brian J. Gates, et al.
Published: (2012-01-01)

Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
by: Brian J. Gates, et al.
Published: (2012-01-01)

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis
by: Calabria S, et al.
Published: (2016-04-01)

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation
by: Boyanov M, et al.
Published: (2012-04-01)

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
by: María J Moro-Álvarez, et al.
Published: (2008-06-01)

Vertebral Collapse Prevented Following Teriparatide Treatment in Postmenopausal Kümmell's Disease Patients with Severe Osteoporosis
by: Peng‐guo Gou, et al.
Published: (2021-04-01)

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
by: Tiao Lin, et al.
Published: (2014-01-01)

Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
by: Sarah Davis, et al.
Published: (2020-06-01)

Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
by: Sarah Davis, et al.
Published: (2020-06-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009-05-01)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017-11-01)

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide
by: Takahiro Mori, et al.
Published: (2019-11-01)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
by: Fujiwara S, et al.
Published: (2014-11-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Teriparatide in the management of osteoporosis
by: Donald Bodenner, et al.
Published: (2008-01-01)

Alendronate and Teriparatide for preventing collapse of osteonecrosis of the femoral head – experiment using a rat model
by: Yao-Tien Tung, et al.
Published: (2010)

Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
by: Chen M, et al.
Published: (2016-03-01)

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Seven years&rsquo; experience with alendronate in postmenopausal Japanese women with osteoporosis
by: Jun Iwamoto, et al.
Published: (2010-04-01)

Therapy of Osteoporosis in Men with Teriparatide
by: Natalie E. Cusano, et al.
Published: (2011-01-01)

Teriparatide - Indications beyond osteoporosis
by: Marilyn Lee Cheng, et al.
Published: (2012-01-01)

Teriparatide as option for severe osteoporosis
by: Mara CARSOTE, et al.
Published: (2016-12-01)

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
by: Virgínia Fernandes Moça Trevisani, et al.